Top

Reactions Weekly

Published in:

01-05-2022 | Empagliflozin | Case report

Empagliflozin/testosterone/testosterone-cipionate

Erythrocytosis: 3 case reports

Published in: Reactions Weekly | Issue 1/2022

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Schumacher K. Abstract #1152223: Hereditary Hemochromatosis Gene Mutation in Patients Developing Erythrocytosis on Combined Testosterone Replacement and SGLT-2 Inhibitor Therapy: A Case Series. Endocrine Practice 28 (Suppl.): S19-S20 abstr. 1152223, No. 5, May 2022. Available from: URL: http://doi.org/10.1016/j.eprac.2022.03.062 [abstract]

Title: Empagliflozin/testosterone/testosterone-cipionate
Erythrocytosis: 3 case reports
Publication date: 01-05-2022
Publisher: Springer International Publishing
Keywords: Empagliflozin
Testosterone
Hypogonadism
Type 2 Diabetes
Published in: Reactions Weekly / Issue 1/2022
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-022-15975-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Empagliflozin/testosterone/testosterone-cipionate

Erythrocytosis: 3 case reports

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2022

Droperidol/olanzapine interaction

Amiodarone

Empagliflozin

Lemborexant

Lutetium-(177lu)-vipivotide-tetraxetan

Multiple drugs